Literature DB >> 23041631

A novel murine infection model for Shiga toxin-producing Escherichia coli.

Emily M Mallick1, Megan E McBee, Vijay K Vanguri, Angela R Melton-Celsa, Katherine Schlieper, Brad J Karalius, Alison D O'Brien, Joan R Butterton, John M Leong, David B Schauer.   

Abstract

Enterohemorrhagic E. coli (EHEC) is an important subset of Shiga toxin-producing (Stx-producing) E. coli (STEC), pathogens that have been implicated in outbreaks of food-borne illness and can cause intestinal and systemic disease, including severe renal damage. Upon attachment to intestinal epithelium, EHEC generates "attaching and effacing" (AE) lesions characterized by intimate attachment and actin rearrangement upon host cell binding. Stx produced in the gut transverses the intestinal epithelium, causing vascular damage that leads to systemic disease. Models of EHEC infection in conventional mice do not manifest key features of disease, such as AE lesions, intestinal damage, and systemic illness. In order to develop an infection model that better reflects the pathogenesis of this subset of STEC, we constructed an Stx-producing strain of Citrobacter rodentium, a murine AE pathogen that otherwise lacks Stx. Mice infected with Stx-producing C. rodentium developed AE lesions on the intestinal epithelium and Stx-dependent intestinal inflammatory damage. Further, the mice experienced lethal infection characterized by histopathological and functional kidney damage. The development of a murine model that encompasses AE lesion formation and Stx-mediated tissue damage will provide a new platform upon which to identify EHEC alterations of host epithelium that contribute to systemic disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23041631      PMCID: PMC3484439          DOI: 10.1172/JCI62746

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  122 in total

1.  Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7.

Authors:  Krystle L Mohawk; Angela R Melton-Celsa; Cory M Robinson; Alison D O'Brien
Journal:  Vaccine       Date:  2010-05-14       Impact factor: 3.641

Review 2.  Biomarkers of kidney injury.

Authors:  Anja Urbschat; Nicholas Obermüller; Axel Haferkamp
Journal:  Biomarkers       Date:  2011-07       Impact factor: 2.658

3.  Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II.

Authors:  E A Wadolkowski; L M Sung; J A Burris; J E Samuel; A D O'Brien
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

Review 4.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

Review 5.  Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia.

Authors:  S A Luperchio; D B Schauer
Journal:  Microbes Infect       Date:  2001-04       Impact factor: 2.700

6.  The use of lambda plac-Mu hybrid phages in Klebsiella pneumoniae and the isolation of stable Hfr strains.

Authors:  U Wehmeier; G A Sprenger; J W Lengeler
Journal:  Mol Gen Genet       Date:  1989-02

7.  The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia.

Authors:  D B Schauer; S Falkow
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

Review 8.  Treatment of acute renal failure.

Authors:  R A Star
Journal:  Kidney Int       Date:  1998-12       Impact factor: 10.612

Review 9.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

10.  Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice.

Authors:  A R Melton-Celsa; S C Darnell; A D O'Brien
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

View more
  45 in total

1.  The Serotonin Neurotransmitter Modulates Virulence of Enteric Pathogens.

Authors:  Aman Kumar; Regan M Russell; Reed Pifer; Zelia Menezes-Garcia; Santiago Cuesta; Sanjeev Narayanan; John B MacMillan; Vanessa Sperandio
Journal:  Cell Host Microbe       Date:  2020-06-09       Impact factor: 21.023

Review 2.  Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity.

Authors:  D J Silberger; C L Zindl; C T Weaver
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

3.  Actin pedestal formation by enterohemorrhagic Escherichia coli enhances bacterial host cell attachment and concomitant type III translocation.

Authors:  Scott E Battle; Michael J Brady; Sivapriya Kailasan Vanaja; John M Leong; Gail A Hecht
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

4.  Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue.

Authors:  Teresa M DesRochers; Erica Palma Kimmerling; Dakshina M Jandhyala; Wassim El-Jouni; Jing Zhou; Cheleste M Thorpe; John M Leong; David L Kaplan
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

5.  Citrobacter rodentium Lysogenized with a Shiga Toxin-Producing Phage: A Murine Model for Shiga Toxin-Producing E. coli Infection.

Authors:  Laurice J Flowers; Shenglan Hu; Anishma Shrestha; Amanda J Martinot; John M Leong; Marcia S Osburne
Journal:  Methods Mol Biol       Date:  2021

6.  Identification of Antibiotics That Diminish Disease in a Murine Model of Enterohemorrhagic Escherichia coli Infection.

Authors:  Sabrina Mühlen; Isabell Ramming; Marina C Pils; Martin Koeppel; Jana Glaser; John Leong; Antje Flieger; Bärbel Stecher; Petra Dersch
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

7.  Bacterial Outer Membrane Vesicles Mediate Cytosolic Localization of LPS and Caspase-11 Activation.

Authors:  Sivapriya Kailasan Vanaja; Ashley J Russo; Bharat Behl; Ishita Banerjee; Maya Yankova; Sachin D Deshmukh; Vijay A K Rathinam
Journal:  Cell       Date:  2016-05-05       Impact factor: 41.582

8.  The gut commensal Bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape.

Authors:  Meredith M Curtis; Zeping Hu; Claire Klimko; Sanjeev Narayanan; Ralph Deberardinis; Vanessa Sperandio
Journal:  Cell Host Microbe       Date:  2014-12-10       Impact factor: 21.023

Review 9.  Pathogenicity, host responses and implications for management of enterohemorrhagic Escherichia coli O157:H7 infection.

Authors:  Nathan K Ho; Aleah C Henry; Kathene Johnson-Henry; Philip M Sherman
Journal:  Can J Gastroenterol       Date:  2013       Impact factor: 3.522

Review 10.  Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection.

Authors:  Victor A Garcia-Angulo; Anjana Kalita; Alfredo G Torres
Journal:  Vaccine       Date:  2013-05-22       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.